Americans are saving far less than normal in 2023. Here’s why
The U.S. personal savings rate fell in 2022 after excess savings from pandemic stimulus bolstered deposits. The slowdown could introduce economic headwinds.
How to set up a budget: An easy guide for college students and recent grads
If you’re a college student or recent grad, you need a budget. It will help ensure you have money for essentials — and the fun stuff! Here’s how to get started.
Amazon stock dips as uncertain cloud outlook overshadows revenue beat
Amazon reported first-quarter sales on Thursday that beat analysts’ estimates.
U.S. GDP rose at a 1.1% pace in the first quarter as signs build that the economy is slowing
Gross domestic product was expected to increase at an annualized pace of 2% in the first quarter, according to Dow Jones.
Musk met with Schumer and other lawmakers to discuss A.I. regulation
The meeting comes after Schumer recently launched an effort to develop a new framework to foster the technology while mitigating its biggest risks.
Il Makiage parent Oddity buys biotech startup Revela to design new molecules for beauty products
The company will use AI-based molecule discovery, a common tool in pharmaceutical drug development, to target cosmetics pain points like hair loss and aging.
The UK blocked Microsoft’s Activision deal. Here’s what it means for U.S. regulators
While having another major regulator also find competition issues in the deal may be encouraging for the FTC, the road ahead is still not straightforward.
Eli Lilly misses on earnings but raises full-year guidance
The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.
Southwest posts wider-than-expected loss as toll of holiday crisis stretches into 2023
Southwest Airlines lost $159 million in the first quarter as the financial impact of its holiday meltdown stretched well into 2023.
Merck results beat expectations despite a big drop in sales of Covid antiviral treatment
Despite the drop in molnupiravir sales, Merck’s revenue and adjusted earnings for the first quarter beat Wall Street’s expectations.
